{"entity":{"id":"nct05067530","kind":"trial","name":"Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a \"Window of Opportunity\" Study","aka":["CAREGIVER"],"tldr":"A phase 2 trial of palbociclib, paclitaxel / nab-paclitaxel and carboplatin in triple-negative breast cancer, run by Medical University of Gdansk, not yet recruiting.","summary":"Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a \"Window of Opportunity\" Study is a phase 2, randomised interventional study registered as NCT05067530 by Medical University of Gdansk, with a registry enrolment figure of 126 participants, started 2022-01-01 and due to reach its primary completion in 2025-01-01. Interventions recorded: Palbociclib; Paclitaxel; Carboplatin. Conditions listed: Triple Negative Breast Neoplasms. Triple-negative eligibility wording from the registry: \"* triple negative tumor defined as:\". Sites: Poland. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT05067530","url":"https://clinicaltrials.gov/study/NCT05067530"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-early"],"sections":[],"technologies":["cytotoxic-chemotherapy","platinum"],"targets":[],"drugs":["palbociclib","paclitaxel","carboplatin"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05067530","phase":"2","setting":"Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a \"Window of Opportunity\" Study","sponsor":"Medical University of Gdansk","enrolled":126,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05067530/","neighbours":{"cancer":[{"id":"tnbc-early","kind":"cancer","name":"Early triple-negative breast cancer","route":"/cancers/tnbc-early/"}],"technology":[{"id":"cytotoxic-chemotherapy","kind":"technology","name":"Cytotoxic chemotherapy","route":"/technologies/cytotoxic-chemotherapy/"},{"id":"platinum","kind":"technology","name":"Platinum agents","route":"/technologies/platinum/"}],"drug":[{"id":"carboplatin","kind":"drug","name":"Carboplatin","route":"/drugs/carboplatin/"},{"id":"paclitaxel","kind":"drug","name":"Paclitaxel / nab-paclitaxel","route":"/drugs/paclitaxel/"},{"id":"palbociclib","kind":"drug","name":"Palbociclib","route":"/drugs/palbociclib/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}